NCDRC orders JnJ to pay Rs 35 lakh compensation for faulty hip replacement device

Published On 2024-10-03 12:37 GMT   |   Update On 2024-10-03 12:37 GMT

In a significant ruling, the National Consumer Disputes Redressal Commission (NCDRC) has ordered Johnson & Johnson Limited to compensate a consumer with Rs 35 lakh for medical complications arising from the company's defective hip replacement device. The commission, comprised of presiding member Ram Surat Maurya along with members Subhash Chandra and Inder Jit Singh, was hearing a complaint filed by Purushotham Lohia, who had sought Rs 5 crore in compensation after suffering ongoing health issues following the use of the DePuy's Acetabular System Resurfacing (ASR XL) hip implant.

According to Lohia, he underwent total hip replacement surgery with the ASR XL device. It said that though the opposite parties reimbursed Rs 25 lakh for Lohia's revision surgery, in May 2017, no compensation was paid for his losses.

For more details, click the link below


Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News